The nasal and oral cavities are potential sites of infection and replication of the SARS-CoV-2 virus during the initial stage of COVID-19.
SARS-CoV-2 is an enveloped virus of the Coronaviridae family. Its outer envelope (pericapsid) consists of a phospholipid bilayer membrane
The medical devices ViruBLOC Nasal Microgel and ViruBLOC Oral Fresh consist of a particular synergy of ingredients, which perform three actions of chemical-physical and mechanical nature:
- TRAP: by creating a transient and osmotically-active mucoadhesive barrier, which traps the viruses.
- DEACTIVATE: the lipid/amphiphilic structure (i.e., having both hydrophobic and hydrophilic properties) of Nicomenthyl® (menthyl nicotinate, a vitamin B3 derivative) interferes with the viruses’ pericapsids (which also have a lipid/amphiphilic structure), disrupting their molecular conformation and preventing them from penetrating and infecting the cells.
- PROTECT: the ViruBLOC system creates an effective protective barrier against coronaviruses, helping to strengthen the natural action of humectation, hydration and defense of mucous secretions.